由KDOQI及KDIGO 2020年指南探讨慢性肾脏病患者蛋白质和能量摄入推荐量  

Recommended intakes of protein and energy in patients with chronic kidney disease:from guidelines of KDOQI and KDIGO in 2020

作　　者：程改平[1] 石运莹[2] 刘婧 曾小庆[1] 柳园[1] Cheng Gaiping;Shi Yunying;Liu Jing;Zeng Xiaoqing;Liu Yuan(Department of Clinical Nutrition,West China Hospital,Sichuan University,Chengdu 610041,China;Department of Nephrology,West China Hospital,Sichuan University,Chengdu 610041,China)

机构地区：[1]四川大学华西医院临床营养科,成都610041 [2]四川大学华西医院肾脏内科,成都610041

出　　处：《中华医学杂志》2021年第18期1287-1290,共4页National Medical Journal of China

基　　金：国家重点研发计划(2016YFD0400604-04);广东省重点领域研发计划项目(2019B020213002)。

摘　　要：蛋白质和能量推荐量是慢性肾脏病(CKD)患者医学营养治疗(MNT)管理的重点。2020年9月,美国国家肾脏基金会肾脏病预后质量倡议(KDOQI)发布CKD营养临床实践指南,对其20年前的营养指南进行了更新。2020年10月,国际肾脏病组织"肾脏病:改善全球预后"(KDIGO)糖尿病工作组发布CKD糖尿病管理临床实践指南。两大指南对CKD患者蛋白质及能量摄入推荐量和观点有所不同。本文结合国内外指南进行讨论,以供临床工作者参考。The recommended intakes of protein and energy play a key role in medical nutrition therapy(MNT)management in patients with chronic kidney disease(CKD).In September 2020,the National Kidney Foundation′s Kidney Disease Outcomes Quality Initiative(KDOQI)released the clinical practice guideline for nutrition in CKD,which updated its previous version published 20 years ago.In October 2020,"Kidney Disease:Improving Global Outcomes(KDIGO)Diabetes Work Group"published KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease.The opinions and recommendations on protein and energy intakes from these two guidelines were different.This article compares and discusses the differences among various national and international guidelines so as to facilitate the clinical practice for CKD patients.

关 键 词：肾病 蛋白质 能量 

分 类 号：R692[医药卫生—泌尿科学] R459.3[医药卫生—外科学]